InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

- Current share price for NTI : $0.014

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$22 New Appointments 23 Oct 2018 8:26AM $0.099 $0.014 fallen by 86.36%
$22 Quarterly report 19 Oct 2018 10:21AM $0.100 $0.014 fallen by 86.50%
$22 Change of Address 8 Oct 2018 2:18PM $0.110 $0.014 fallen by 87.73%
$22 Initial Director's Interest Notice 4 Oct 2018 5:06PM $0.135 $0.014 fallen by 90%
$22 Shipment of Mente Autism devices 4 Oct 2018 8:27AM $0.135 $0.014 fallen by 90%
$22 Appointment of Dr Neale Fong to the Board 3 Oct 2018 6:21PM $0.135 $0.014 fallen by 90%
$22 Mente Autism - FDA Clearance Application 2 Oct 2018 8:24AM $0.135 $0.014 fallen by 90%
$22 Appendix 4E and Annual Report 3 Sep 2018 8:08AM $0.150 $0.014 fallen by 91%
$22 Appendix 4G 31 Aug 2018 4:17PM $0.150 $0.014 fallen by 91%
$22 Corporate Governance Statement 31 Aug 2018 3:54PM $0.150 $0.014 fallen by 91%
$22 Change in substantial holding 20 Aug 2018 8:25AM $0.160 $0.014 fallen by 91.56%
$22 Investor Presentation 13 Aug 2018 8:27AM $0.165 $0.014 fallen by 91.82%
$22 First Shipments of Mente Autism 10 Aug 2018 8:20AM $0.150 $0.014 fallen by 91%
$22 Quarterly report and Appendix 4C 31 Jul 2018 6:33PM $0.165 $0.014 fallen by 91.82%
$22 US Clinical Trial / Investor Webinar 12 Jul 2018 4:58PM $0.175 $0.014 fallen by 92.29%
$22 Webinar Presentation 12 Jul 2018 9:14AM $0.170 $0.014 fallen by 92.06%
$22 Investor Webinar 10 Jul 2018 2:09PM $0.165 $0.014 fallen by 91.82%
$22 US Clinical Trial Results Published 9 Jul 2018 9:31AM $0.155 $0.014 fallen by 91.29%
$22 Initial Director's Interest Notice 6 Jul 2018 11:23AM $0.155 $0.014 fallen by 91.29%
$22 Trading Halt 5 Jul 2018 2:58PM $0.155 $0.014 fallen by 91.29%
$22 Neuroscience expert Dr David Cantor appointed to the board 4 Jul 2018 8:28AM $0.165 $0.014 fallen by 91.82%
$22 Final Director's Interest Notice 28 Jun 2018 11:39AM $0.180 $0.014 fallen by 92.50%
$22 Board Change 28 Jun 2018 8:26AM $0.185 $0.014 fallen by 92.70%
$22 Change in substantial holding 27 Jun 2018 10:57AM $0.180 $0.014 fallen by 92.50%
$22 Clinical Trial Publication Provisionally Accepted 25 Jun 2018 9:39AM $0.120 $0.014 fallen by 88.75%

576 - 600 of 689 results

Page 24 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.